Mecure Industries PLC (NGX:MECURE)

Nigeria · Delayed Price · Currency is NGN

85.45

0.00 (0.00%)

At close: Jul 10, 2026

557.31% (1Y)

Market Cap	341.80B +669.8%
Revenue (ttm)	84.55B +65.0%
Net Income	7.23B +220.7%
EPS	1.81 +220.7%
Shares Out	4.00B
PE Ratio	47.24
Forward PE	n/a
Dividend	0.32 (0.37%)
Ex-Dividend Date	Apr 24, 2026

Volume	38,520
Open	n/a
Previous Close	85.45
Day's Range	n/a
52-Week Range	11.20 - 104.00
Beta	1.31
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About Mecure Industries

Mecure Industries PLC manufactures and sells pharmaceuticals in Nigeria. The company engages in distributing multivitamins products. It also offers antibiotics, antimalarials, antihypertensives, antidiabetics, analgesics and nsaids, proton pump inhibitors, and H2 receptor antagonists. In addition, the company provides blood tonics; cough, cold, and catarrh preparations; antihistamines; anthelmintic; antacids; steroids; antispasmodics; and antidiarrheals. Further, it is involved in the contract manufacturing services. It sells its products throu... [Read more]

Industry Pharmaceutical Preparations

Founded 2005

Employees 195

Stock Exchange Nigerian Stock Exchange

Ticker Symbol MECURE

Full Company Profile

Financial Performance

In 2025, Mecure Industries's revenue was 77.69 billion, an increase of 68.80% compared to the previous year's 46.03 billion. Earnings were 6.46 billion, an increase of 177.52%.

Financial Statements